Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 10.083 |
|
|||||
| News | - |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Revelation Biosciences Inc | REVBW | NASDAQ | Equity Warrant |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,0002 | 2,04% | 0,01 | 22:02:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,0098 | 0,0098 | 0,01 | 0,01 | 0,0098 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen |
|---|---|---|---|---|
| 8 | 10.083 | 0,0097999 | 99 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 22:23:06 | 1 | 0,0063 | USD |
Finanzwerte REVBW
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 39,08k | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Revelation Biosciences
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 24.6.2026 | 22:47 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01.6.2026 | 23:26 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11.5.2026 | 15:56 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 11.5.2026 | 14:45 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 07.5.2026 | 22:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.5.2026 | 22:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 01.5.2026 | 23:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 30.4.2026 | 22:31 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 15.4.2026 | 22:13 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 19.3.2026 | 21:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 26.2.2026 | 22:25 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.2.2026 | 18:35 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
Forum Revelation Biosciences
Keine Diskussionen Gefunden.Neuen Thread Erstellen
REVBW Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:REVBW -
What is the current Revelation Biosciences Inc share price?
The current share price of Revelation Biosciences Inc is US$ 0,01
What is the 1 year trading range for Revelation Biosciences Inc share price?
Revelation Biosciences Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
